CLINICAL TRIAL / NCT01990040

Registry for Participants With Short Bowel Syndrome

  • Observational
  • OPEN TO ACCRUAL
  • NCT01990040

A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome

This is a global prospective, observational, multi-center registry to evaluate the long-term safety profile for participants with short bowel syndrome (SBS) who are treated with teduglutide in a routine clinical setting. The registry will also evaluate the long-term clinical outcomes in participants with SBS. SBS participants treated and not treated with teduglutide will be enrolled.